Summary of “Why do digital health startups keep failing?”

Zeo is just one of many digital health startups whose early promise failed to materialize into lasting impact.
Many digital health companies fall short because they apply a strategy to healthcare that was developed and refined in the tech sector, an entirely different industry with its own set of rules.
Consumer technology startups often push quickly to get a minimum viable product to market and then iterate to improve that product based on what most resonates with consumers.
Digital health products need to appeal not just to individual consumers but to a complicated landscape of stakeholders-from doctors and patients to regulators and insurers-all of whom have a say in whether a new technology is adopted.
This is why 61% of digital health companies that start B2C end up pivoting to B2B and selling to insurance companies, employers, hospitals, or other healthcare providers.
Arlen Myers, president of the Society of Physician Entrepreneurs, echoes these concerns, indicating that many digital health startups fail because they “Don’t involve end users early and often enough … don’t satisfy the needs of multiple stakeholders … make products that interfere with physician workflow instead of making it easier … [or] launch products that are not clinically validated.”
48 medical device and digital health companies have originated from projects undertaken in Stanford Biodesign’s fellowships and classes, and the solutions they have developed have provided care for more than 1.5 million patients.
As digital health continues to take off, success will be determined by getting the need right, designing innovative solutions that address stakeholders’ top priorities, and then demonstrating that a product provides better results.

The orginal article.